ScholarIQanswers from OpenAlex & ORCID
Charles D. Blanke
ResearcherPublications, citations & collaboration network
Charles D. Blanke is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Charles D. Blanke have?
ScholarIQindexed works
Charles D. Blanke has 544 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Charles D. Blanke have?
ScholarIQcitation count
Charles D. Blanke has 33,142 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Charles D. Blanke?
ScholarIQh-index
Charles D. Blanke has an h-index of 73 in OpenAlex.
What is the i10-index of Charles D. Blanke?
ScholarIQi10-index
Charles D. Blanke has an i10-index of 215 in OpenAlex.
What is the OpenAlex record for Charles D. Blanke?
ScholarIQopenalex
The OpenAlex for Charles D. Blanke is on the source record.
What are the most-cited papers on Charles D. Blanke?
ScholarIQmost cited works
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With <i>KRAS</i> Wild-Type Advanced or Metastatic Colorectal Cancer
Alan P. Venook, Donna Niedzwiecki, Heinz‐Josef Lenz, Federico Innocenti, Briant Fruth, Jeffrey A. Meyerhardt, Deborah Schrag, Claire Greene, Bert H. O’Neil, James N. Atkins, Scott Berry, Blasé N. Polite, Eileen M. O’Reilly, Richard M. Goldberg, Howard S. Höchster, Richard L. Schilsky, Monica M. Bertagnolli, Anthony B. El-Khoueiry, Peter J. Watson, Al B. Benson, Daniel Mulkerin, Robert J. Mayer, Charles D. Blanke
Next steps for adolescent and young adult oncology workshop: An update on progress and recommendations for the future
Ashley Wilder Smith, Nita L. Seibel, Denise Riedel Lewis, Karen Albritton, Donald F. Blair, Charles D. Blanke, W. Archie Bleyer, David R. Freyer, Ann M. Geiger, Brandon Hayes‐Lattin, James V. Tricoli, Lynne I. Wagner, Brad Zebrack
Combining tumor deposits with the number of lymph node metastases to improve the prognostic accuracy in stage III colon cancer: a post hoc analysis of the CALGB/SWOG 80702 phase III study (Alliance)☆
Romain Cohen, Q. Shi, J. Meyers, Zhe Jin, Magali Svrcek, Charles S. Fuchs, Félix Couture, Philip Kuebler, Kristen K. Ciombor, Johanna C. Bendell, Ana De Jesus‐Acosta, Pankaj Kumar, DeQuincy Andrew Lewis, Benjamin Kye Jyn Tan, Monica M. Bertagnolli, P. Philip, Charles D. Blanke, Eileen M. O’Reilly, Aaron Shields, Jeffrey A. Meyerhardt